This Article Full Text Full Text (PDF) All Versions of this Article: 200309-1322SOv1 170/1/22    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kotloff, R. M. Articles by Crawford, S. W. Search for Related Content PubMed PubMed Citation Articles by Kotloff, R. M. Articles by Crawford, S. W.

Pulmonary Complications of Solid Organ and Hematopoietic Stem Cell Transplantation

Section of Advanced Lung Disease and Lung Transplantation, Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania; and Pulmonary and Critical Care Division, Naval Medical Center, San Diego, California

Correspondence and requests for reprints should be addressed to Robert M. Kotloff, M.D., 838 West Gates, University of Pennsylvania Medical Center, 3400 Spruce Street, Philadelphia, PA 19027. E-mail: kotloff{at}mail.med.upenn.edu

The ability to successfully transplant solid organs and hematopoietic stem cells represents one of the landmark medical achievements of the twentieth century. Solid organ transplantation has emerged as the standard of care for select patients with severe vital organ dysfunction and hematopoietic stem cell transplantation has become an important treatment option for patients with a wide spectrum of nonmalignant and malignant hematologic disorders, genetic disorders, and solid tumors. Although advances in surgical techniques, immunosuppressive management, and prophylaxis and treatment of infectious diseases have made long-term survival an achievable goal, transplant recipients remain at high risk for developing a myriad of serious and often life-threatening complications. Paramount among these are pulmonary complications, which arise as a consequence of the immunosuppressed status of the recipient as well as from such factors as the initial surgical insult of organ transplantation, the chemotherapy and radiation conditioning regimens that precede hematopoietic stem cell transplantation, and alloimmune mechanisms mediating host-versus-graft and graft-versus-host responses. As the population of transplant recipients continues to grow and as their care progressively shifts from the university hospital to the community setting, knowledge of the pulmonary complications of transplantation is increasingly germane to the contemporary practice of pulmonary medicine.

Key Words: hematopoietic stem cell transplantation • organ transplantation • pneumonia

This article has been cited by other articles:

				G. Barisione, A. Bacigalupo, E. Crimi, M. T. Van Lint, T. Lamparelli, and V. Brusasco Changes in lung volumes and airway responsiveness following haematopoietic stem cell transplantation Eur. Respir. J., December 1, 2008; 32(6): 1576 - 1582. [Abstract] [Full Text] [PDF]

				A. G. Duarte, L. Terminella, J. T. Smith, A. C. Myers, G. Campbell, and S. Lick Restoration of Cough Reflex in Lung Transplant Recipients Chest, August 1, 2008; 134(2): 310 - 316. [Abstract] [Full Text] [PDF]

				M. R. Pipeling, E. E. West, C. M. Osborne, A. B. Whitlock, L. K. Dropulic, M. H. Willett, M. Forman, A. Valsamakis, J. B. Orens, D. R. Moller, et al. Differential CMV-Specific CD8+ Effector T Cell Responses in the Lung Allograft Predominate over the Blood during Human Primary Infection J. Immunol., July 1, 2008; 181(1): 546 - 556. [Abstract] [Full Text] [PDF]

				M. N. Ballinger, L. L. N. Hubbard, T. R. McMillan, G. B. Toews, M. Peters-Golden, R. Paine III, and B. B. Moore Paradoxical role of alveolar macrophage-derived granulocyte-macrophage colony-stimulating factor in pulmonary host defense post-bone marrow transplantation Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L114 - L122. [Abstract] [Full Text] [PDF]

				D. Stolz, A. Stulz, B. Muller, A. Gratwohl, and M. Tamm BAL Neutrophils, Serum Procalcitonin, and C-Reactive Protein To Predict Bacterial Infection in the Immunocompromised Host Chest, August 1, 2007; 132(2): 504 - 514. [Abstract] [Full Text] [PDF]

				J. G. Parambil, J. L. Myers, M.-C. Aubry, and J. H. Ryu Causes and Prognosis of Diffuse Alveolar Damage Diagnosed on Surgical Lung Biopsy Chest, July 1, 2007; 132(1): 50 - 57. [Abstract] [Full Text] [PDF]

				O.S. Zmeili and A.O. Soubani Pulmonary aspergillosis: a clinical update QJM, June 1, 2007; 100(6): 317 - 334. [Abstract] [Full Text] [PDF]

				M. N. Ballinger, D. M. Aronoff, T. R. McMillan, K. R. Cooke, K. Olkiewicz, G. B. Toews, M. Peters-Golden, and B. B. Moore Critical Role of Prostaglandin E2 Overproduction in Impaired Pulmonary Host Response following Bone Marrow Transplantation J. Immunol., October 15, 2006; 177(8): 5499 - 5508. [Abstract] [Full Text] [PDF]

				T. Franquet, S. Rodriguez, R. Martino, A. Gimenez, T. Salinas, and A. Hidalgo Thin-Section CT Findings in Hematopoietic Stem Cell Transplantation Recipients with Respiratory Virus Pneumonia Am. J. Roentgenol., October 1, 2006; 187(4): 1085 - 1090. [Abstract] [Full Text] [PDF]

				M. D. Duncan and D. S. Wilkes Transplant-related Immunosuppression: A Review of Immunosuppression and Pulmonary Infections Proceedings of the ATS, December 1, 2005; 2(5): 449 - 455. [Abstract] [Full Text] [PDF]

				S. Sharma, H. F. Nadrous, S. G. Peters, A. Tefferi, M. R. Litzow, M.-C. Aubry, and B. Afessa Pulmonary Complications in Adult Blood and Marrow Transplant Recipients: Autopsy Findings Chest, September 1, 2005; 128(3): 1385 - 1392. [Abstract] [Full Text] [PDF]

				D. L. Escuissato, E. L. Gasparetto, E. Marchiori, G. de Melo Rocha, C. Inoue, R. Pasquini, and N. L. Muller Pulmonary Infections After Bone Marrow Transplantation: High-Resolution CT Findings in 111 Patients Am. J. Roentgenol., September 1, 2005; 185(3): 608 - 615. [Abstract] [Full Text] [PDF]

				J. J. Fullmer, L. L. Fan, M. K. Dishop, C. Rodgers, and R. Krance Successful Treatment of Bronchiolitis Obliterans in a Bone Marrow Transplant Patient With Tumor Necrosis Factor-{alpha} Blockade Pediatrics, September 1, 2005; 116(3): 767 - 770. [Abstract] [Full Text] [PDF]

				T. D. Bradley, Y. E. Miller, F. J. Martinez, D. C. Angus, W. MacNee, and E. Abraham Interstitial Lung Disease, Lung Cancer, Lung Transplantation, Pulmonary Vascular Disorders, and Sleep-disordered Breathing in AJRCCM in 2004 Am. J. Respir. Crit. Care Med., April 1, 2005; 171(7): 675 - 685. [Full Text] [PDF]

				D. D. Benoit, E. A. Hoste, P. O. Depuydt, F. C. Offner, N. H. Lameire, K. H. Vandewoude, A. W. Dhondt, L. A. Noens, and J. M. Decruyenaere Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies Nephrol. Dial. Transplant., March 1, 2005; 20(3): 552 - 558. [Abstract] [Full Text] [PDF]

				T. Franquet, N. L. Muller, K. S. Lee, A. Gimenez, and J. D. Flint High-Resolution CT and Pathologic Findings of Noninfectious Pulmonary Complications After Hematopoietic Stem Cell Transplantation Am. J. Roentgenol., February 1, 2005; 184(2): 629 - 637. [Full Text] [PDF]